Clinical Trials Browser

Phase 1 × Advanced Non-small Cell Lung Cancer × pembrolizumab × Clear all

NCT06868732 2025-03-11

Evaluation of JSKN016 Combination Therapy in Subjects with NSCLC

Phase 1 Not yet recruiting

Advanced Non-small Cell Lung Cancer